What is Rapid Micro Biosystems's G&A?

Rapid Micro Biosystems (RPID) reported G&A of $7.44M in Q1 2026.

How has Rapid Micro Biosystems's G&A changed year-over-year?

Rapid Micro Biosystems's G&A increased by 30.8% year-over-year, from $5.69M to $7.44M.

What is the long-term trend for Rapid Micro Biosystems's G&A?

Over 4 years (2021 to 2025), Rapid Micro Biosystems's G&A has grown at a 6.2% compound annual growth rate (CAGR), from $17.9M to $22.75M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Rapid Micro Biosystems RPID G&A

G&A at other companies

iRadimedIRMD

$4.57M-0.9%

Ginkgo BioworksDNA

$37.83M-4.8%

Fulgent Genetics, Inc.FLGT

$27.68M+9.5%

Other financials

Income statement

See full

Revenue$8.0M+11.1%

Gross profit$371.0K-8.2%

Operating income-$13.9M-18.8%

Net income-$14.3M-26.7%

EPS (diluted)-$0.31-19.2%

Balance sheet

See full

Cash & equivalents$14.1M-26.8%

Total debt$23.8M+301%

Total equity$20.4M-68.9%

Total assets$62.4M-27.0%

Cash flow

See full

Operating cash flow-$15.1M-66.1%

CapEx$394.0K+23.5%

Free cash flow-$15.5M-64.7%

Valuation

See full

Market cap$86.19M-43.8%

Enterprise value$95.86M-31.7%

P/S2.5×-2.6×

Profitability

See full

Operating margin-144.2%-12.7pp

Net margin-145.8%-5.0pp

FCF margin-110.5%-14.9pp

Returns & leverage

See full

Return on equity-116.7%-620pp

Debt / equity1.2×+1.1×

Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapid Micro Biosystems's G&A?: Rapid Micro Biosystems (RPID) reported G&A of $7.44M in Q1 2026.
How has Rapid Micro Biosystems's G&A changed year-over-year?: Rapid Micro Biosystems's G&A increased by 30.8% year-over-year, from $5.69M to $7.44M.
What is the long-term trend for Rapid Micro Biosystems's G&A?: Over 4 years (2021 to 2025), Rapid Micro Biosystems's G&A has grown at a 6.2% compound annual growth rate (CAGR), from $17.9M to $22.75M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.